FDG PET/CT in the management of primary pleural tumors and pleural metastases

Matthew Kruse; Steven J. Sherry; Vasavi Paidpally; Gustavo Mercier; Rathan M. Subramaniam

doi:10.2214/AJR.13.10572

FDG PET/CT in the management of primary pleural tumors and pleural metastases

Matthew Kruse, Steven J. Sherry, Vasavi Paidpally, Gustavo Mercier, Rathan M. Subramaniam

Research output: Contribution to journal › Review article › peer-review

36 Scopus citations

Abstract

Objective. FDG PET/CT is emerging as an important modality in the evaluation of pleural tumors. PET/CT has an established role in the diagnosis and staging and shows promise in therapy planning, therapy response assessment, and providing prognostic information in patients with malignant pleural mesothelioma. This modality has distinct advantages in characterizing other primary pleural tumors and pleural metastases. Conclusion. FDG PET/CT is a useful imaging modality in the management of patients with primary pleural tumors and pleural metastases.

Original language	English (US)
Pages (from-to)	W215-W226
Journal	American Journal of Roentgenology
Volume	201
Issue number	2
DOIs	https://doi.org/10.2214/AJR.13.10572
State	Published - Aug 2013

Keywords

Metabolic tumor volume
PET/CT
Pleural metastases
Pleural tumors

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

Access to Document

10.2214/AJR.13.10572

Cite this

@article{df9c5141ed504d87a0f5dfc699230d7b,

title = "FDG PET/CT in the management of primary pleural tumors and pleural metastases",

abstract = "Objective. FDG PET/CT is emerging as an important modality in the evaluation of pleural tumors. PET/CT has an established role in the diagnosis and staging and shows promise in therapy planning, therapy response assessment, and providing prognostic information in patients with malignant pleural mesothelioma. This modality has distinct advantages in characterizing other primary pleural tumors and pleural metastases. Conclusion. FDG PET/CT is a useful imaging modality in the management of patients with primary pleural tumors and pleural metastases.",

keywords = "Metabolic tumor volume, PET/CT, Pleural metastases, Pleural tumors",

author = "Matthew Kruse and Sherry, {Steven J.} and Vasavi Paidpally and Gustavo Mercier and Subramaniam, {Rathan M.}",

year = "2013",

month = aug,

doi = "10.2214/AJR.13.10572",

language = "English (US)",

volume = "201",

pages = "W215--W226",

journal = "American Journal of Roentgenology",

issn = "0361-803X",

publisher = "American Roentgen Ray Society",

number = "2",

}

TY - JOUR

T1 - FDG PET/CT in the management of primary pleural tumors and pleural metastases

AU - Kruse, Matthew

AU - Sherry, Steven J.

AU - Paidpally, Vasavi

AU - Mercier, Gustavo

AU - Subramaniam, Rathan M.

PY - 2013/8

Y1 - 2013/8

N2 - Objective. FDG PET/CT is emerging as an important modality in the evaluation of pleural tumors. PET/CT has an established role in the diagnosis and staging and shows promise in therapy planning, therapy response assessment, and providing prognostic information in patients with malignant pleural mesothelioma. This modality has distinct advantages in characterizing other primary pleural tumors and pleural metastases. Conclusion. FDG PET/CT is a useful imaging modality in the management of patients with primary pleural tumors and pleural metastases.

AB - Objective. FDG PET/CT is emerging as an important modality in the evaluation of pleural tumors. PET/CT has an established role in the diagnosis and staging and shows promise in therapy planning, therapy response assessment, and providing prognostic information in patients with malignant pleural mesothelioma. This modality has distinct advantages in characterizing other primary pleural tumors and pleural metastases. Conclusion. FDG PET/CT is a useful imaging modality in the management of patients with primary pleural tumors and pleural metastases.

KW - Metabolic tumor volume

KW - PET/CT

KW - Pleural metastases

KW - Pleural tumors

UR - http://www.scopus.com/inward/record.url?scp=84883663750&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883663750&partnerID=8YFLogxK

U2 - 10.2214/AJR.13.10572

DO - 10.2214/AJR.13.10572

M3 - Review article

C2 - 23883236

AN - SCOPUS:84883663750

SN - 0361-803X

VL - 201

SP - W215-W226

JO - American Journal of Roentgenology

JF - American Journal of Roentgenology

IS - 2

ER -

FDG PET/CT in the management of primary pleural tumors and pleural metastases

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this